Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
With 16 new drugs potentially launching in the next five years, it is anticipated that new challengers will account for roughly $70 billion of the total incretin-based drug market, which is expected to reach $200 billion by 2031
There are also novel formulations only available from compounding pharmacies, such as sublingual semaglutide and tirzepatide tablets that may be placed under the tongue
About this article Cite this article Guerreiro, G., Deon, M., Becker, G.S
Recombinant lipases and phospholipases and their use as biocatalysts for industrial applications
US$ 29.69
US$ 24.27
US$ 20.85
US$ 23.80
